New to the slide, but not a new discussion. In
Post# of 30027
(Total Views: 416)
Posted On: 07/06/2018 7:39:14 PM
New to the slide, but not a new discussion.
In the beginning of the year this was posted.
Amarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS
"The recent peer-reviewed article in the scientific journal Pigment Cell & Melanoma Research entitled "Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermalepidermal engineered skin substitutes" demonstrates the potential to safely add melanocytes to ESS to produce pigmented skin that is similar in color to original donor skin pigment. Pigmented ESS would potentially improve outcomes for burn victims, as well as significantly expand the market opportunity for ESS into the $130B global cosmetic skin care market."
https://globenewswire.com/news-release/2018/0...d-ESS.html
Referring article
Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermal–epidermal engineered skin substitutes
Steven T. Boyce
Christopher M. Lloyd
Mark C. Kleiner
Viki B. Swope
Zalfa Abdel‐Malek
Dorothy M. Supp
First published: 22 June 2017
https://onlinelibrary.wiley.com/doi/full/10.1111/pcmr.12609
Just so much to try and keep track of.....
Aloha
In the beginning of the year this was posted.
Amarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS
"The recent peer-reviewed article in the scientific journal Pigment Cell & Melanoma Research entitled "Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermalepidermal engineered skin substitutes" demonstrates the potential to safely add melanocytes to ESS to produce pigmented skin that is similar in color to original donor skin pigment. Pigmented ESS would potentially improve outcomes for burn victims, as well as significantly expand the market opportunity for ESS into the $130B global cosmetic skin care market."
https://globenewswire.com/news-release/2018/0...d-ESS.html
Referring article
Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermal–epidermal engineered skin substitutes
Steven T. Boyce
Christopher M. Lloyd
Mark C. Kleiner
Viki B. Swope
Zalfa Abdel‐Malek
Dorothy M. Supp
First published: 22 June 2017
https://onlinelibrary.wiley.com/doi/full/10.1111/pcmr.12609
Just so much to try and keep track of.....
Aloha
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼